Table 3.
Compound No. | Classification | The major targets | Activity (µM) | References |
---|---|---|---|---|
36–44 | Triptolide derivatives | Protect nerve cells from Aβ1-42 damage Inhibits LPS induce TNF |
_ | 51 |
45/46 | Andrographolide derivatives | Inhibits LPS induced NO production, iNOS expression and proinflammatory cytokine TNF- α and IL-6 Protect neurons from microglia mediated neurotoxicity Promotes NGF induced axon growth in PC12 cells |
_ | 52 |
47-49 | β-Secretase inhibitors AChE inhibitory activity |
_ | 53 | |
50 | Glycyrrhetinic acid derivatives | AChE inhibitory activity | IC50 (hAChE) = 3.43 | 54 |
51 | IC50 (hAChE) = 5.39 | |||
52 | IC50 (hAChE) = 6.27 | |||
53 | IC50 (hAChE) = 8.68 | |||
54 | BChE inhibitory activity | IC50 (hBChE) = 5.43 | 55 | |
55 | IC50 (hBChE) = 9.81 | |||
56 | Safranal derivatives | MAO-A inhibitory activity MAO-B inhibitory activity |
IC50 (hMAO-A) = 9.93 IC50 (hMAO-B) = 0.0091 |
56 |